Merck & Co. (NYSE:MRK) is a prominent American multinational pharmaceutical company many investors know for its brand-name ...

The FDA on Tuesday signed off on SpringWorks Therapeutics’ mirdametinib—now to carry the brand name Gomekli—for the treatment ...

Goldman Sachs analyst Salveen Richter highlights potential benefits for biopharma from 340B reforms, while Medicaid cuts ...

The healthcare pioneer shares insights on transformative diagnostics where precision medicine meets women’s health innovation ...

The app, which pioneered commission-free trading, amassed 13 million user accounts and gained significant brand recognition ... reaching $7.4 billion. Merck & Co., Inc. (NYSE:MRK) is making ...

What will it take for a clinical-stage biotech to break into the cardio space? One CEO thinks he has the answer.

Palantir stock surges as artificial-intelligence gains drive an earnings and revenue beat, while China begins an antitrust ...

MSD said that its sotatercept steering committee called for the trial to end as patients are moved to the ongoing open-label ...

Visitors can capture their photos with the Red Card at the stand to contribute to a powerful visual Mosaic symbol of collective action against Type 2 Diabetes ...

Merck, a leading science and technology company, and Opentrons Labworks, Inc., a leader in lab automation and accessible robotics, announced a multi-year agreement to automate assay kits on a custom ...

NEW YORK, Jan. 22 (UPI) --As demand for weight-loss injections sold under brand names such as ... apnea FDA says shortage of GLP-1 drug tirzepatide is over Merck reaches weight-loss drug deal ...